|
시장보고서
상품코드
1901646
유전체 공학 시장 - 산업 규모, 점유율, 동향, 기회 및 예측 : 기술별, 제공 방법별, 용도별, 최종 사용자별, 지역별 경쟁(2021-2031년)Genome Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Delivery Method, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
세계의 유전체 공학 시장은 2025년 114억 1,000만 달러에서 2031년까지 284억 5,000만 달러에 달하고, CAGR 16.45%를 보일 것으로 예측됩니다.
유전체 공학은 CRISPR-Cas9, TALENs, ZFNs 등의 기술을 이용하여 DNA 서열의 삽입, 삭제, 또는 개조를 실시함으로써 생물의 유전물질을 정밀하게 개조하는 기술입니다. 이 시장의 주요 성장 요인은 유전성 및 만성 질환의 유병률 상승 외에도 유전체 연구에 대한 많은 투자와 농업 및 치료 분야에서 유전자 편집 기술의 응용 확대에 있습니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2027-2031년 |
| 시장 규모 : 2025년 | 114억 1,000만 달러 |
| 시장 규모 : 2031년 | 284억 5,000만 달러 |
| CAGR : 2026-2031년 | 16.45% |
| 가장 빠르게 성장하는 부문 | CRISPR |
| 가장 큰 시장 | 북미 |
주요 시장 성장 촉진요인
CRISPR과 차세대 편집 도구의 지속적인 발전으로 유전체 공학은 실험적 조사에서 상업적으로 실현 가능한 치료법으로 전환하여 시장이 근본적으로 재구성되었습니다. 이 변화는 겸상 적혈구 빈혈증과 베타 탈라세미아에 대한 최초의 CRISPR 기반 치료법의 규제 성공과 후속 상업 전개에 의해 현저하게 나타났습니다.
주요 시장 과제
고가의 치료비와 상환 모델의 복잡성은 유전체 엔지니어링 시장의 성장에 큰 장벽이 되고 있습니다. 유전체 의약품 개발에는 자본 집약적인 R&D 프로세스가 수반되며, 투자를 회수하기 위해서는 높은 가격 설정이 필수적입니다.
주요 시장 동향
인공지능(AI)과 머신러닝의 통합은 편집 도구의 정확성 향상을 통해 유전체 설계의 풍경을 근본적으로 변화시키고 있습니다. 이러한 컴퓨팅 기술을 통해 연구자들은 오프타겟 효과를 예측하고 가이드 RNA 서열을 전례 없는 속도로 최적화할 수 있게 되어 치료법 개발의 타임라인을 대폭 단축하고 있습니다.
자주 묻는 질문
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 유전체 공학 시장 전망
- 시장 규모 및 예측
- 금액별
- 시장 점유율 및 예측
- 기술별(CRISPR, TALEN, ZFN, 안티센스, 기타)
- 전달 방법별(Ex-Vivo 대 In-Vivo)
- 용도별(세포주 공학, 유전자 공학, 진단 용도, 신약개발, 기타)
- 최종 사용자별(제약 및 바이오테크놀러지 기업, 학술 및 연구기관, 기타)
- 지역별
- 기업별(2025년)
- 시장 맵
제6장 북미의 유전체 공학 시장 전망
- 시장 규모 및 예측
- 시장 점유율 및 예측
- 북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코
제7장 유럽의 유전체 공학 시장 전망
- 시장 규모 및 예측
- 시장 점유율 및 예측
- 유럽 : 국가별 분석
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
제8장 아시아태평양의 유전체 공학 시장 전망
- 시장 규모 및 예측
- 시장 점유율 및 예측
- 아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주
제9장 중동 및 아프리카의 유전체 공학 시장 전망
- 시장 규모 및 예측
- 시장 점유율 및 예측
- 중동 및 아프리카 : 국가별 분석
- 사우디아라비아
- 아랍에미리트(UAE)
- 남아프리카
제10장 남미의 유전체 공학 시장 전망
- 시장 규모 및 예측
- 시장 점유율 및 예측
- 남미 : 국가별 분석
- 브라질
- 콜롬비아
- 아르헨티나
제11장 시장 역학
- 성장 촉진요인
- 과제
제12장 시장 동향과 발전
- 인수합병
- 제품 출시
- 최근 동향
제13장 세계의 유전체 공학 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
- 업계 내 경쟁
- 신규 진입 가능성
- 공급자의 힘
- 고객의 힘
- 대체품의 위협
제15장 경쟁 구도
- Merck KGaA
- Sangamo Therapeutics, Inc.
- GenScript Biotech Corp
- CRISPR Therapeutics AG
- Editas Medicine, Inc.
- Precision BioSciences, Inc.
- Horizon Discovery Group plc
- Lonza Group Ltd.
- OriGene Technologies, Inc.
- Transposagen Biopharmaceuticals, Inc.
제16장 전략적 제안
제17장 기업 소개와 면책사항
JHS 26.01.20The Global Genome Engineering Market will grow from USD 11.41 Billion in 2025 to USD 28.45 Billion by 2031 at a 16.45% CAGR. Genome engineering is the precise modification of an organism's genetic material using technologies such as CRISPR-Cas9, TALENs, and ZFNs to insert, delete, or alter DNA sequences. The market is primarily driven by the rising prevalence of genetic and chronic diseases, coupled with substantial investments in genomic research and the expanding application of gene editing in agriculture and therapeutics.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 11.41 Billion |
| Market Size 2031 | USD 28.45 Billion |
| CAGR 2026-2031 | 16.45% |
| Fastest Growing Segment | CRISPR |
| Largest Market | North America |
Key Market Drivers
Continuous advancements in CRISPR and next-generation editing tools are fundamentally reshaping the market by transitioning genome engineering from experimental research to commercially viable therapeutics. This shift is exemplified by the regulatory success and subsequent commercial rollout of the first CRISPR-based treatments for sickle cell disease and beta-thalassemia. The ability to precisely correct genetic defects ex vivo has validated the clinical utility of these technologies, encouraging rapid adoption across healthcare systems and validating the commercial potential of gene-edited medicines.
Key Market Challenges
The high cost of treatment and the complexity of reimbursement models constitute a substantial barrier to the growth of the genome engineering market. Developing genomic medicines involves capital-intensive research and manufacturing processes which necessitates high pricing to recoup investments. Consequently, these elevated costs place a severe strain on healthcare budgets and insurance providers often limiting patient eligibility and delaying coverage decisions. This financial friction prevents these therapies from reaching a wider patient population, thereby restricting the total addressable market and slowing the revenue generation required to sustain further industry innovation.
Key Market Trends
The integration of artificial intelligence and machine learning is fundamentally altering the genomic design landscape by improving the precision of editing tools. These computational technologies enable researchers to predict off-target effects and optimize guide RNA sequences with unprecedented speed, significantly reducing the timeline for therapeutic development. This convergence of biology and computation is attracting massive investment to support generative models that can design novel biological systems from scratch.
Key Market Players
- Merck KGaA
- Sangamo Therapeutics, Inc.
- GenScript Biotech Corp
- CRISPR Therapeutics AG
- Editas Medicine, Inc.
- Precision BioSciences, Inc.
- Horizon Discovery Group plc
- Lonza Group Ltd.
- OriGene Technologies, Inc.
- Transposagen Biopharmaceuticals, Inc.
Report Scope:
In this report, the Global Genome Engineering Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Genome Engineering Market, By Technology:
- CRISPR
- TALEN
- ZFN
- Antisense
- Others
Genome Engineering Market, By Delivery Method:
- Ex-Vivo v/s In-Vivo
Genome Engineering Market, By Application:
- Cell Line Engineering
- Genetic Engineering
- Diagnostic Applications
- Drug Discovery & Development
- Others
Genome Engineering Market, By End User:
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutions
- Others
Genome Engineering Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Genome Engineering Market.
Available Customizations:
Global Genome Engineering Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Genome Engineering Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Technology (CRISPR, TALEN, ZFN, Antisense, Others)
- 5.2.2. By Delivery Method (Ex-Vivo v/s In-Vivo)
- 5.2.3. By Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, Others)
- 5.2.4. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
- 5.2.5. By Region
- 5.2.6. By Company (2025)
- 5.3. Market Map
6. North America Genome Engineering Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Technology
- 6.2.2. By Delivery Method
- 6.2.3. By Application
- 6.2.4. By End User
- 6.2.5. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Genome Engineering Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Technology
- 6.3.1.2.2. By Delivery Method
- 6.3.1.2.3. By Application
- 6.3.1.2.4. By End User
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Genome Engineering Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Technology
- 6.3.2.2.2. By Delivery Method
- 6.3.2.2.3. By Application
- 6.3.2.2.4. By End User
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Genome Engineering Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Technology
- 6.3.3.2.2. By Delivery Method
- 6.3.3.2.3. By Application
- 6.3.3.2.4. By End User
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Genome Engineering Market Outlook
7. Europe Genome Engineering Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Technology
- 7.2.2. By Delivery Method
- 7.2.3. By Application
- 7.2.4. By End User
- 7.2.5. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Genome Engineering Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Technology
- 7.3.1.2.2. By Delivery Method
- 7.3.1.2.3. By Application
- 7.3.1.2.4. By End User
- 7.3.1.1. Market Size & Forecast
- 7.3.2. France Genome Engineering Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Technology
- 7.3.2.2.2. By Delivery Method
- 7.3.2.2.3. By Application
- 7.3.2.2.4. By End User
- 7.3.2.1. Market Size & Forecast
- 7.3.3. United Kingdom Genome Engineering Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Technology
- 7.3.3.2.2. By Delivery Method
- 7.3.3.2.3. By Application
- 7.3.3.2.4. By End User
- 7.3.3.1. Market Size & Forecast
- 7.3.4. Italy Genome Engineering Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Technology
- 7.3.4.2.2. By Delivery Method
- 7.3.4.2.3. By Application
- 7.3.4.2.4. By End User
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Genome Engineering Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Technology
- 7.3.5.2.2. By Delivery Method
- 7.3.5.2.3. By Application
- 7.3.5.2.4. By End User
- 7.3.5.1. Market Size & Forecast
- 7.3.1. Germany Genome Engineering Market Outlook
8. Asia Pacific Genome Engineering Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Technology
- 8.2.2. By Delivery Method
- 8.2.3. By Application
- 8.2.4. By End User
- 8.2.5. By Country
- 8.3. Asia Pacific: Country Analysis
- 8.3.1. China Genome Engineering Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Technology
- 8.3.1.2.2. By Delivery Method
- 8.3.1.2.3. By Application
- 8.3.1.2.4. By End User
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Genome Engineering Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Technology
- 8.3.2.2.2. By Delivery Method
- 8.3.2.2.3. By Application
- 8.3.2.2.4. By End User
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Genome Engineering Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Technology
- 8.3.3.2.2. By Delivery Method
- 8.3.3.2.3. By Application
- 8.3.3.2.4. By End User
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Genome Engineering Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Technology
- 8.3.4.2.2. By Delivery Method
- 8.3.4.2.3. By Application
- 8.3.4.2.4. By End User
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Genome Engineering Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Technology
- 8.3.5.2.2. By Delivery Method
- 8.3.5.2.3. By Application
- 8.3.5.2.4. By End User
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Genome Engineering Market Outlook
9. Middle East & Africa Genome Engineering Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Technology
- 9.2.2. By Delivery Method
- 9.2.3. By Application
- 9.2.4. By End User
- 9.2.5. By Country
- 9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Genome Engineering Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Technology
- 9.3.1.2.2. By Delivery Method
- 9.3.1.2.3. By Application
- 9.3.1.2.4. By End User
- 9.3.1.1. Market Size & Forecast
- 9.3.2. UAE Genome Engineering Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Technology
- 9.3.2.2.2. By Delivery Method
- 9.3.2.2.3. By Application
- 9.3.2.2.4. By End User
- 9.3.2.1. Market Size & Forecast
- 9.3.3. South Africa Genome Engineering Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Technology
- 9.3.3.2.2. By Delivery Method
- 9.3.3.2.3. By Application
- 9.3.3.2.4. By End User
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Saudi Arabia Genome Engineering Market Outlook
10. South America Genome Engineering Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Technology
- 10.2.2. By Delivery Method
- 10.2.3. By Application
- 10.2.4. By End User
- 10.2.5. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Genome Engineering Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Technology
- 10.3.1.2.2. By Delivery Method
- 10.3.1.2.3. By Application
- 10.3.1.2.4. By End User
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Colombia Genome Engineering Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Technology
- 10.3.2.2.2. By Delivery Method
- 10.3.2.2.3. By Application
- 10.3.2.2.4. By End User
- 10.3.2.1. Market Size & Forecast
- 10.3.3. Argentina Genome Engineering Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Technology
- 10.3.3.2.2. By Delivery Method
- 10.3.3.2.3. By Application
- 10.3.3.2.4. By End User
- 10.3.3.1. Market Size & Forecast
- 10.3.1. Brazil Genome Engineering Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Global Genome Engineering Market: SWOT Analysis
14. Porter's Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
15. Competitive Landscape
- 15.1. Merck KGaA
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
- 15.2. Sangamo Therapeutics, Inc.
- 15.3. GenScript Biotech Corp
- 15.4. CRISPR Therapeutics AG
- 15.5. Editas Medicine, Inc.
- 15.6. Precision BioSciences, Inc.
- 15.7. Horizon Discovery Group plc
- 15.8. Lonza Group Ltd.
- 15.9. OriGene Technologies, Inc.
- 15.10. Transposagen Biopharmaceuticals, Inc.
